Bausch & Lomb (BLCO) Change in Accured Expenses (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Change in Accured Expenses came in at $95.0 million in Q2 2026, down 2.06% YoY from $97.0 million in Q2 2025, and up 201.06% on a QoQ basis from -$94.0 million in Q1 2026.
Bausch & Lomb (BLCO) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Change in Accured Expenses data on file, last reported at $95.0 million in Q2 2026.
- Quarterly Change in Accured Expenses fell 2.06% year-over-year to $95.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $35.0 million (down 42.62% YoY) and the FY2025 annual result came in at $108.0 million, down 14.29% from the prior year.
- Change in Accured Expenses advanced to $95.0 million in Q2 2026, from -$94.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $188.0 million in Q4 2023 to a low of -$107.0 million in Q4 2024.
- A 5-year average of $37.2 million and a median of $45.0 million in 2023 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 5300.0% in 2023, down 325.0% in 2023.
- Tracing BLCO's Change in Accured Expenses over 5 years: stood at $110.0 million in 2022, then soared by 70.91% to $188.0 million in 2023, then tumbled by 156.91% to -$107.0 million in 2024, then soared by 98.13% to -$2.0 million in 2025, then soared by 4850.0% to $95.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $95.0 million (Q2 2026), -$94.0 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 95.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.00 Mn |
| Jun 30, 2026 | 95.00 Mn |
| Mar 31, 2026 | -94.00 Mn |
| Mar 31, 2026 | -94.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Jun 30, 2025 | 97.00 Mn |
| Jun 30, 2025 | 97.00 Mn |
| Mar 31, 2025 | -23.00 Mn |
| Mar 31, 2025 | -23.00 Mn |
| Dec 31, 2024 | -107.00 Mn |
| Dec 31, 2024 | -107.00 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Mar 31, 2024 | 70.00 Mn |